347 related articles for article (PubMed ID: 10496300)
21. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
22. Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
Huang L; Carey V; Lindsey JC; Marzan F; Gingrich D; Graham B; Barlow-Mosha L; Ssemambo PK; Kamthunzi P; Nachman S; Parikh S; Aweeka FT;
PLoS One; 2017; 12(10):e0186589. PubMed ID: 29065172
[TBL] [Abstract][Full Text] [Related]
23. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.
Piola P; Fogg C; Bajunirwe F; Biraro S; Grandesso F; Ruzagira E; Babigumira J; Kigozi I; Kiguli J; Kyomuhendo J; Ferradini L; Taylor W; Checchi F; Guthmann JP
Lancet; 2005 Apr 23-29; 365(9469):1467-73. PubMed ID: 15850630
[TBL] [Abstract][Full Text] [Related]
24. Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.
Parikh S; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Gao Q; Li F; Were M; Kakuru A; Achan J; Mwebaza N; Aweeka FT
Clin Infect Dis; 2016 Aug; 63(3):414-22. PubMed ID: 27143666
[TBL] [Abstract][Full Text] [Related]
25. Suspected allergy to artemether-lumefantrine treatment of malaria.
Krippner R; Staples J
J Travel Med; 2003; 10(5):303-5. PubMed ID: 14531988
[No Abstract] [Full Text] [Related]
26. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria.
Borrmann S; Sallas WM; Machevo S; González R; Björkman A; Mårtensson A; Hamel M; Juma E; Peshu J; Ogutu B; Djimdé A; D'Alessandro U; Marrast AC; Lefèvre G; Kern SE
Trop Med Int Health; 2010 Apr; 15(4):434-41. PubMed ID: 20180933
[TBL] [Abstract][Full Text] [Related]
27. Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border.
Kloprogge F; McGready R; Hanpithakpong W; Blessborn D; Day NP; White NJ; Nosten F; Tarning J
Antimicrob Agents Chemother; 2015 Oct; 59(10):6375-84. PubMed ID: 26239986
[TBL] [Abstract][Full Text] [Related]
28. Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.
Parashar D; Aditya NP; Murthy RS
Drug Deliv; 2016; 23(1):123-9. PubMed ID: 24786480
[TBL] [Abstract][Full Text] [Related]
29. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study.
Hatz C; Soto J; Nothdurft HD; Zoller T; Weitzel T; Loutan L; Bricaire F; Gay F; Burchard GD; Andriano K; Lefèvre G; De Palacios PI; Genton B
Am J Trop Med Hyg; 2008 Feb; 78(2):241-7. PubMed ID: 18256423
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial.
Kakuda TN; DeMasi R; van Delft Y; Mohammed P
HIV Med; 2013 Aug; 14(7):421-9. PubMed ID: 23441978
[TBL] [Abstract][Full Text] [Related]
31. Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed-dose combination in the treatment of uncomplicated Plasmodium falciparum malaria.
Pareek A; Chandurkar N; Srivastav V; Lakhani J; Karmakar PS; Basu S; Ray A; Pednekar S; Gupta PB; Suthar N; Lakhani S
Trop Med Int Health; 2013 May; 18(5):578-87. PubMed ID: 23489465
[TBL] [Abstract][Full Text] [Related]
32. Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.
Kloprogge F; Workman L; Borrmann S; Tékété M; Lefèvre G; Hamed K; Piola P; Ursing J; Kofoed PE; Mårtensson A; Ngasala B; Björkman A; Ashton M; Friberg Hietala S; Aweeka F; Parikh S; Mwai L; Davis TME; Karunajeewa H; Salman S; Checchi F; Fogg C; Newton PN; Mayxay M; Deloron P; Faucher JF; Nosten F; Ashley EA; McGready R; van Vugt M; Proux S; Price RN; Karbwang J; Ezzet F; Bakshi R; Stepniewska K; White NJ; Guerin PJ; Barnes KI; Tarning J
PLoS Med; 2018 Jun; 15(6):e1002579. PubMed ID: 29894518
[TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.
Staehli Hodel EM; Guidi M; Zanolari B; Mercier T; Duong S; Kabanywanyi AM; Ariey F; Buclin T; Beck HP; Decosterd LA; Olliaro P; Genton B; Csajka C
Malar J; 2013 Jul; 12():235. PubMed ID: 23841950
[TBL] [Abstract][Full Text] [Related]
34. Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria.
van Agtmael MA; Cheng-Qi S; Qing JX; Mull R; van Boxtel CJ
Int J Antimicrob Agents; 1999 Jul; 12(2):151-8. PubMed ID: 10418761
[TBL] [Abstract][Full Text] [Related]
35. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms.
Malmberg M; Ferreira PE; Tarning J; Ursing J; Ngasala B; Björkman A; Mårtensson A; Gil JP
J Infect Dis; 2013 Mar; 207(5):842-7. PubMed ID: 23225895
[TBL] [Abstract][Full Text] [Related]
36. MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy.
Vos K; Sciuto CL; Piedade R; Ashton M; Björkman A; Ngasala B; Mårtensson A; Gil JP
Pharmacogenomics; 2017 Jul; 18(10):981-985. PubMed ID: 28639487
[TBL] [Abstract][Full Text] [Related]
37. Artemether-lumefantrine (Coartem) for treatment of malaria.
Med Lett Drugs Ther; 2009 Sep; 51(1321):75-6. PubMed ID: 19763049
[No Abstract] [Full Text] [Related]
38. In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand.
Pilz JB; Wernsdorfer G; Sirichaisinthop J; Rojanawatsirivet C; Wiedermann G; Wernsdorfer WH
Wien Klin Wochenschr; 2004; 116 Suppl 4():41-6. PubMed ID: 15683042
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of benflumetol given as a fixed combination artemether-benflumetol (CGP 56697) in Thai patients with uncomplicated falciparum malaria.
Na-Bangchang K; Karbwang J; Tasanor U; Thanavibul A; Farkad E; Mull R
Int J Clin Pharmacol Res; 1999; 19(2):41-6. PubMed ID: 10669897
[TBL] [Abstract][Full Text] [Related]
40. Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.
Mutagonda RF; Kamuhabwa AA; Minzi OM; Massawe SN; Maganda BA; Aklillu E
Malar J; 2016 May; 15(1):278. PubMed ID: 27177586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
